24 employees
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives.
2001
$7.8M
from 3 investors over 3 rounds
Mutabilis raised $6.4M on September 1, 2020
Investors: CARB-X
Mutabilis raised $7.8M on January 6, 2020
Investors: REPAIR Impact Fund
Mutabilis raised undisclosed on January 1, 2004
Investors: Omnes